Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Will a Hybrid Concierge Medicine Model Work for Rheumatologists?

Wayne Lipton  |  September 1, 2014

Growing number of specialists explore membership-based medicine model to help stabilize practice costs, improve patient satisfaction

Filed under:FacilityPractice SupportWorkforce Tagged with:costsMedicaremedicinememberpatient carePractice Managementrheumatologistspecialist

Is Shared Decision Making Possible in Rheumatology?

James T. Rosenbaum, MD  |  August 1, 2014

A rheumatologist voices skepticism that physicians, patients can arrive at mutually shared healthcare decisions

Filed under:Biologics/DMARDsConditionsDrug UpdatesOther Rheumatic ConditionsPractice SupportQuality Assurance/ImprovementRheumatoid ArthritisWorkforce Tagged with:BiologicsdrugMedicareMethotrexatepatient carephysicianPractice ManagementprednisoneRheumatoid arthritisrheumatologistSarcoidosisSteroids

Autoimmune Myelofibrosis: A Case Review

Mell Gutarra-Arana, MD; Theniat Haider, MD; Theodore Kieffer, MD; & Steven Hugenberg, MD  |  August 1, 2014

Diagnosis, treatment and management of AMF in Hispanic patient with lupus

Filed under:AnalgesicsConditionsDrug UpdatesSystemic Lupus ErythematosusSystemic Sclerosis Tagged with:ANA titerdrugGlucocorticoidsLupuspatient careprednisoneSclerodermaSteroidssystemic lupus erythematosus (SLE)Treatment

Avoid Data Breaches, HIPAA Violations When Posting Patients’ Protected Health Information Online

Steven M. Harris, Esq.  |  July 1, 2014

Learn how to de-identify patient information before sharing it over social media or by other means

Filed under:Information TechnologyLegal UpdatesProfessional TopicsTechnology Tagged with:HIPAAInternetLegalprivacyrheumatologistTechnology

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  June 1, 2014

Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisResearch Rheum Tagged with:anti-inflammatoryBiologicsBiosimilarscelecoxib (Elyxyb)corticosteroid psychosisMethotrexatePsoriatic ArthritisradiographraloxifeneResearchrituximabSafety

Lessons Learned from a Patient with Rheumatoid Arthritis

Sarah Troxell, RN, BSN  |  June 1, 2014

Sarah Troxell, RN, BSN, imparts what she’s learned about RA and medication management, assembling a team of health professionals and battling other health issues

Filed under:ConditionsOther Rheumatic ConditionsProfilesRheumatoid Arthritis Tagged with:Antiphospholipid Antibody Syndrome (APS)Association of Rheumatology Professionals (ARP)BiologicsHughes SyndromeMethotrexateprednisoneProfileRARheumatoid arthritisrheumatologistrituximabTroxell

Update on Healthcare Reform in 2014 under the Affordable Care Act

Joseph Flood, MD, & Kam Nola, PharmD, MS  |  June 1, 2014

The American College of Rheumatology continues to monitor healthcare system changes under the ACA; educate rheumatologists, rheumatology health professionals

Filed under:Legislation & AdvocacyPractice SupportPresident's PerspectiveProfessional TopicsQuality Assurance/Improvement Tagged with:AC&RACAAdvocacyAffordable Care Act (ACA)American College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BiosimilarsFloodLegislationMedicarePQRSPractice Management

Why Farber Disease May Be Misdiagnosed as Juvenile Idiopathic Arthritis

Boris Hugle, MD, MSc, Laura Mueller & Thierry Levade, MD, PhD  |  June 1, 2014

A case study reveals how late presentation of this rare, autosomal-recessive disorder, which can involve arthritis-like symptoms, can be mistaken for JIA

Filed under:ConditionsRheumatoid Arthritis Tagged with:Juvenile idiopathic arthritisMethotrexatepatient careRheumatoid arthritisrheumatologist

Rheuminations: Ankylosing Spondylitis Sometimes Defies Detection

Simon M. Helfgott, MD  |  May 1, 2014

How method of diagnosing, treating this inflammatory back disease characterized by stiffness and the presence of HLA-B27 gene has evolved

Filed under:Axial SpondyloarthritisConditionsOpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:Ankylosing Spondylitisanti-inflammatorygeriatricsPainpatient careResearchrheumatologistrheumatologyTreatment

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  April 2, 2014

Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:BiologicsdrugDrug SafetyMethotrexateOsteoporosisRheumatoid arthritisrheumatologySafetySystemic lupus erythematosus

  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 127
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences